Company Filing History:
Years Active: 2003-2016
Title: Innovator Samuel Michael Owens: Pioneering Advances in Substance Use Treatment
Introduction
Samuel Michael Owens, an accomplished inventor based in Little Rock, Arkansas, has made significant contributions in the field of pharmaceutical sciences. With a total of six patents to his name, Owens focuses on innovative solutions to address the challenges posed by substance use, particularly methamphetamine.
Latest Patents
Owens' most recent patents showcase his dedication to developing effective treatments for substance dependency. One of his notable inventions is related to "methamphetamine-like hapten compounds, linkers, carriers, and compositions and uses thereof." This invention involves hapten compounds that comprise either (+) methamphetamine or (+) amphetamine conjugated to a linker. The compounds are designed to elicit an immune response to substances such as (+) methamphetamine, (+) amphetamine, or (+) MDMA.
Another significant patent is centered around "anti-(+) methamphetamine monoclonal antibodies." This invention includes compositions and methods for treating symptoms associated with methamphetamine use. The approach aims to slow the entry of (+) methamphetamine into the brain of a subject through the administration of an effective amount of an anti-(+) methamphetamine antibody.
Career Highlights
Owens is notably affiliated with the University of Arkansas, where he continues his research and innovation efforts. His academic and professional endeavors in this reputable institution facilitate collaboration with other experts and help drive his inventive progress.
Collaborations
Throughout his career, Owens has worked alongside notable colleagues, including Frank Ivy Carroll and Philip Abraham. His collaborative efforts with fellow researchers have amplified the impact of his inventions, fostering advancements in their shared field of study.
Conclusion
Samuel Michael Owens stands out as an influential inventor whose work has the potential to transform the treatment landscape for substance use disorders. As he continues to innovate at the University of Arkansas, his contributions will likely have a lasting impact on both the scientific community and society at large.